Clinical Trial Update: Study Evaluating Isovorin in Colon Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Isovorin (Leucovorin) for colon cancer has completed, sponsored by Wyeth (now Pfizer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Isovorin (Leucovorin)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Colon Cancer | Phase 3 | Status: COMPLETED